🔎 Trials Near Me

Beranda › Kanker Prostat › Kentucky

Uji klinis Kanker Prostat di Kentucky

19 studi untuk Kanker Prostat mencari peserta di lokasi di Kentucky.

Kota di Kentucky

Teks studi resmi (Bahasa Inggris)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
  • Commonwealth Cancer Center-Corbin, Corbin
  • Saint Elizabeth Healthcare Edgewood, Edgewood
  • dan 5 lainnya
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Saint Elizabeth Healthcare Edgewood, Edgewood
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06632977

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • University of Kentucky/Markey Cancer Center, Lexington
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT03866382

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

  • Graves Gilbert Clinic, Bowling Green
Menerima pesertaStudi observasional
Usia 40 hingga 75 · Pria · Diperbarui 28 Sep 2026 · NCT07543757

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • University of Louisville Health - James Graham Brown Cancer Center, Louisville
  • Norton Cancer Institute, Louisville
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 22 Sep 2026 · NCT07213674

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  • Robley Rex VA Medical Center, Louisville, KY, Louisville
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 17 Sep 2026 · NCT05011383

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • University of Kentucky Chandler Medical Center ( Site 0048), Lexington
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 17 Sep 2026 · NCT06925737

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Baptist Health Hardin, Elizabethtown
  • Saint Joseph Hospital, Lexington
  • Saint Joseph Radiation Oncology Resource Center, Lexington
  • dan 3 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05946213

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • CommonSpirit Saint Joseph Hospital - Lexington, Lexington
  • Saint Joseph Radiation Oncology Resource Center, Lexington
  • CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 19 Agu 2026 · NCT04423211

Comparing Acupuncture vs. Sham Acupuncture for the Management of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy

  • University of Kentucky, Lexington
Menerima peserta
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07594002

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
  • Commonwealth Cancer Center-Corbin, Corbin
  • CommonSpirit Saint Joseph Hospital - Lexington, Lexington
  • dan 8 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 14 Jul 2026 · NCT06592924

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

  • University of Kentucky/Markey Cancer Center, Lexington
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 14 Jul 2026 · NCT05691465

Pembro With Radiation With or Without Olaparib

  • University of Kentucky, Lexington
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 14 Jul 2026 · NCT05568550

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

  • UK Markey Cancer Center, Lexington
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT05283330

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  • University of Kentucky Markey Cancer Center, Lexington
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT06778863

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

  • Flaget Memorial Hospital, Bardstown
  • Commonwealth Cancer Center-Corbin, Corbin
  • Saint Joseph Hospital, Lexington
  • dan 4 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 29 Jan 2026 · NCT05806515

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Baptist Corbin, Corbin
  • Baptist Hardin, Elizabethtown
  • Baptist Lexington, Lexington
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT05366881

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 115, Louisville
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Nov 2025 · NCT05914116

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • Saint Joseph Radiation Oncology Resource Center, Lexington
  • Saint Joseph Hospital East, Lexington
  • University of Kentucky/Markey Cancer Center, Lexington
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 11 Sep 2025 · NCT03678025

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.